Celebrex may 1 day be used to prevent and even treat breast tumors The anti-inflammatory medication Celebrex, or celecoxib, reduces tumor mass by encouraging cell death and discouraging both cell proliferation and the sprouting of new blood vessels that feed growing tumors, according to a study reported in the November problem of Molecular Cancer Research tratamiento-del-acne.html . The study, conducted by experts at the Mayo Clinic University of Medicine in Scottsdale, Ariz., suggests this drug one day might be used to avoid and even treat breast tumors. Celebrex, marketed by Pfizer Inc., is an associate of the general family of drugs that target the COX-2, an enzyme that plays a major role in arthritis pain and inflammation.
It’s a huge honor and privilege because of what the award represents, said Shane, who also received the pharmacist society’s award for distinguished leadership in 2005. The reputation from my peers means a lot to me. Shane started her career at Cedars-Sinai in 1977 as an intern pharmacist after making her doctorate from USC’s School of Pharmacy. She became a clinical pharmacist in pediatrics and rose steadily to become director of pharmacy services in 1988. Simultaneously, she ascended the ranks of academia, beginning as an associate scientific professor at USC and afterwards earning an appointment as assistant dean of scientific pharmacy at UC San Francisco’s School of Pharmacy.